Autonomic Pharmacology (Ar) - Lec 05 - Amphetamine and Ephedrine

Main Ideas

1. Indirect Sympathomimetics: Amphetamine

Indirect-acting drugs increase neurotransmitter activity without directly activating alpha or beta receptors. Mixed-acting drugs have both indirect and direct effects.

Amphetamine is an indirect sympathomimetic that enters the central nervous system (CNS). It promotes the release of norepinephrine, dopamine, and serotonin from nerve endings and inhibits their reuptake, leaving more neurotransmitter in the synaptic space.

This stimulation can cause alertness, wakefulness, reduced appetite, and euphoria. At higher levels of exposure, it may cause hallucinations, delusions, and psychosis. Because amphetamine can reduce fatigue and appetite while increasing alertness, it has a high potential for misuse and dependence. The lecturer notes that it has been restricted or withdrawn in many places.

Related medicines discussed in the lecture include:

• Methylphenidate, an amphetamine-related medicine used for ADHD to improve attention and reduce hyperactivity.
• Modafinil, a wakefulness-promoting medicine used for narcolepsy, which the lecture describes as a disorder involving sudden sleep episodes.

Excessive CNS stimulation can cause adverse effects such as insomnia, rapid heartbeat, nervousness, irritability, and seizures. The lecture warns that stimulant drugs can be risky for people prone to seizures.

2. Cocaine

Cocaine is a plant-derived alkaloid from the coca plant with stimulant effects. The lecture explains that it prevents neurotransmitter reuptake, causing neurotransmitters to accumulate in synapses and producing effects similar to those of amphetamine.

Cocaine is also described as a local anesthetic, with historical use in eye procedures. Toxicity can involve CNS stimulation, including agitation and seizures. The lecturer says benzodiazepines are used to calm CNS overstimulation in overdose.

3. Mixed-Acting Sympathomimetic: Ephedrine

Ephedrine is classified as mixed-acting because it directly stimulates alpha and beta receptors and indirectly increases norepinephrine release.

It originates from the Ephedra plant. The lecturer says its broad, non-selective effects have contributed to its limited use. The lecture mentions historical uses for respiratory symptoms and bedwetting, but emphasizes that ephedrine is not commonly used today.

Pseudoephedrine, a related drug, is used as a decongestant through alpha-1-mediated vasoconstriction.

The lecturer highlights urinary retention as a concern, especially for older men with an enlarged prostate. The explanation given is that ephedrine’s longer duration allows its effects to persist, unlike the short-lived effects of adrenaline.

Terminology Note

Some auto-generated terms are clearly mistranscribed. For example, references to “apoptosis” and “transducers” appear to mean neurotransmitter reuptake and neurotransmitters, respectively. This summary uses the apparent intended meanings.

Speakers and Sources

• Primary lecturer: Abdel-Motaal Fouda, identified in the video metadata as a clinical pharmacology professor.
• Narcolepsy clip source: The metadata identifies a YouTube clip at https://youtu.be/5ZGuWm7fNmM. No separate speaker from that clip is identifiable in the supplied subtitles.